Mohammadali Yavari Ramsheh
Overview
Explore the profile of Mohammadali Yavari Ramsheh including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
449
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Diver S, Haldar K, McDowell P, Busby J, Mistry V, Micieli C, et al.
Allergy
. 2022 Jul;
77(11):3362-3376.
PMID: 35778780
Background: In T2-mediated severe asthma, biologic therapies, such as mepolizumab, are increasingly used to control disease. Current biomarkers can indicate adequate suppression of T2 inflammation, but it is unclear whether...
2.
Ramsheh M, Haldar K, Esteve-Codina A, Purser L, Richardson M, Muller-Quernheim J, et al.
Lancet Microbe
. 2022 May;
2(7):e300-e310.
PMID: 35544166
Background: Chronic obstructive pulmonary disease (COPD) is associated with airway inflammation and bacterial dysbiosis. The relationship between the airway microbiome and bronchial gene expression in COPD is poorly understood. We...
3.
Yousuf A, Mohammed S, Carr L, Ramsheh M, Micieli C, Mistry V, et al.
Lancet Respir Med
. 2022 Mar;
10(5):469-477.
PMID: 35339234
Background: Chronic obstructive pulmonary disease (COPD) is a heterogeneous inflammatory airway disease. The epithelial-derived IL-33 and its receptor ST2 have been implicated in airway inflammation and infection. We aimed to...
4.
Wang Z, Locantore N, Haldar K, Ramsheh M, Beech A, Ma W, et al.
Am J Respir Crit Care Med
. 2020 Dec;
203(12):1488-1502.
PMID: 33332995
Understanding the role of the airway microbiome in chronic obstructive pulmonary disease (COPD) inflammatory endotypes may help to develop microbiome-based diagnostic and therapeutic approaches. To understand the association of the...
5.
Haldar K, George L, Wang Z, Mistry V, Ramsheh M, Free R, et al.
Respir Res
. 2020 Jul;
21(1):183.
PMID: 32664956
Background: Airway bacterial dysbiosis is a feature of chronic obstructive pulmonary disease (COPD). However, there is limited comparative data of the lung microbiome between healthy smokers, non-smokers and COPD. Methods:...
6.
Ramsheh M, Haldar K, Bafadhel M, George L, Free R, John C, et al.
Thorax
. 2019 Nov;
75(1):8-16.
PMID: 31699806
Background: Antibiotic resistance is a major global threat. We hypothesised that the chronic obstructive pulmonary disease (COPD) airway is a reservoir of antimicrobial resistance genes (ARGs) that associate with microbiome-specific...
7.
George L, Wright A, Mistry V, Sutcliffe A, Chachi L, Haldar K, et al.
Int J Chron Obstruct Pulmon Dis
. 2019 Jun;
14:1177-1185.
PMID: 31239655
We hypothesized whether the reduction in eosinophilic airway inflammation in patients with chronic obstructive pulmonary disease (COPD) following treatment with benralizumab, a humanized, afucosylated, monoclonal antibody that binds to interleukin-5...
8.
Haldar K, Bafadhel M, Lau K, Berg A, Kwambana B, Kebadze T, et al.
PLoS One
. 2017 Aug;
12(8):e0182833.
PMID: 28841671
Background: While a subgroup of patients with exacerbations of chronic obstructive pulmonary disease (COPD) clearly benefit from antibiotics, their identification remains challenging. We hypothesised that selective assessment of the balance...
9.
Wang Z, Bafadhel M, Haldar K, Spivak A, Mayhew D, Miller B, et al.
Eur Respir J
. 2016 Feb;
47(4):1082-92.
PMID: 26917613
Increasing evidence suggests that the lung microbiome plays an important role in chronic obstructive pulmonary disease (COPD) severity. However, the dynamics of the lung microbiome during COPD exacerbations and its...